Evidence map›Paper›PMID 22180614›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Pre-B cell leukemia homeobox 1 is associated with lupus susceptibility in mice and humans.

Carla M Cuda, Shiwu Li, Shujuan Liang, Yiming Yin, Hari Hara S K Potula, Zhiwei Xu, Mayami Sengupta, Yifang Chen, Edward Butfiloski, Henry Baker and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. IL-4 alters TLR7-induced B cell developmental program in lupus.Clinical immunology (Orlando, Fla.) · 2025
    Article
  3. Review
  4. Lupus susceptibility geneScience advances · 2024
    Article
  5. Molecular Mechanisms of Lupus Susceptibility Allele PBX1D.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. PBX1: a key character of the hallmarks of cancer.Journal of molecular medicine (Berlin, Germany) · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Metabolic Factors that Contribute to Lupus Pathogenesis.Critical reviews in immunology · 2016
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Carla M CudaDepartment of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA.
Shiwu Li
Shujuan Liang
Yiming Yin
Hari Hara S K Potula
Zhiwei Xu
Mayami Sengupta
Yifang Chen
Edward Butfiloski
Henry Baker
Lung-Ji Chang
Igor Dozmorov
Eric S Sobel
Laurence Morel
University of Florida · USFlorida College · USOklahoma Medical Research Foundation · US

Funding

UF Clinical and Translational Science AwardUL1TR000064 · NCATS · UNIVERSITY OF FLORIDA · PI NELSON, DAVID R · 2012 to 2014
$12.2M
Characterization of SLE-susceptibility loci on mouse chromosome 1R01AI045050 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Laurence Morel · 2000 to 2026
$11.5M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
NCATS NIH HHS UL1 TR000064NIAID NIH HHS R01 AI045050NIAMS NIH HHS P30 AR053483
6 · The paper itself

Abstract

Sle1a.1 is part of the Sle1 susceptibility locus, which has the strongest association with lupus nephritis in the NZM2410 mouse model. In this study, we show that Sle1a.1 results in the production of activated and autoreactive CD4(+) T cells. Additionally, Sle1a.1 expression reduces the peripheral regulatory T cell pool, as well as induces a defective response of CD4(+) T cells to the retinoic acid expansion of TGF-β-induced regulatory T cells. At the molecular level, Sle1a.1 corresponds to an increased expression of a novel splice isoform of Pbx1, Pbx1-d. Pbx1-d overexpression is sufficient to induce an activated/inflammatory phenotype in Jurkat T cells and to decrease their apoptotic response to retinoic acid. PBX1-d is expressed more frequently in the CD4(+) T cells from lupus patients than from healthy controls, and its presence correlates with an increased central memory T cell population. These findings indicate that Pbx1 is a novel lupus susceptibility gene that regulates T cell activation and tolerance.

Indexed as

Genetic Predisposition to DiseaseAdultAnimalsDNA-Binding ProteinsFemaleHomeodomain ProteinsHumansImmune ToleranceImmunologic MemoryJurkat CellsLupus Erythematosus, SystemicLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicDNA-Binding ProteinsHomeodomain ProteinsPBX1 protein, humanPbx1 protein, mousePre-B-Cell Leukemia Transcription Factor 1Protein IsoformsProto-Oncogene ProteinsTranscription Factors

Identifiers

PMID22180614
PMCPMC3253202
OpenAlexW2152611201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.